Hypotensive Anesthesia for Jaw Surgery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests three medications—Dexmedetomidine, Nicardipine, and Labetalol—to lower blood pressure during jaw surgery. The goal is to determine which medication improves surgical visibility, reduces blood loss, and maintains surgery time, while also monitoring side effects. Healthy adults needing jaw surgery at Boston Medical Center, who are not on certain heart medications, might qualify. As a Phase 4 trial, this research aims to understand how these FDA-approved treatments benefit a broader range of patients.
Will I have to stop taking my current medications?
The trial requires that you stop taking certain medications if you are on them at home, specifically beta blockers, calcium channel blockers, and alpha 2 agonists.
What is the safety track record for these treatments?
Research shows that the three medications in this trial—Dexmedetomidine, Nicardipine, and Labetalol—are generally safe and well-tolerated for lowering blood pressure during jaw surgery.
Studies have found that Dexmedetomidine effectively reduces blood loss and improves patient recovery, with no major side effects reported. It also helps lessen pain, nausea, and vomiting after surgery.
Nicardipine lowers blood pressure during surgeries without causing harmful effects. Temporary changes in kidney function can occur, but these usually return to normal after use.
Labetalol safely manages blood pressure during surgery in healthy patients. While effective, it may cause a slow heart rate, known as bradycardia, in some cases.
Since this trial is in a late stage (Phase 4), these medications have been tested before and are considered safe for use in this context.12345Why are researchers enthusiastic about this study treatment?
Researchers are excited about the use of hypotensive anesthesia in jaw surgery because it utilizes medications like Nicardipine, Labetalol, and Dexmedetomidine to lower blood pressure in a targeted way. Unlike standard anesthesia practices, which may not specifically aim to reduce blood pressure, these drugs help control bleeding during surgery, potentially improving surgical outcomes and recovery times. Each medication offers a unique approach: Nicardipine is a calcium channel blocker, Labetalol combines alpha and beta-blocking properties, and Dexmedetomidine provides sedative effects with minimal respiratory depression. These distinct mechanisms provide tailored options for anesthesiologists to optimize patient care during complex jaw surgeries.
What evidence suggests that this trial's treatments could be effective for jaw surgery?
This trial will compare the effects of different hypotensive anesthesia medications during jaw surgery. Participants will be randomized into one of three groups: the Dexmedetomidine group, the Nicardipine group, or the Labetalol group. Research has shown that dexmedetomidine can reduce blood loss by more than 50% and alleviate pain and nausea after surgery. Studies have found that nicardipine effectively lowers blood pressure, improving the surgical area and reducing blood loss. Labetalol also lowers blood pressure during surgery, helping to control blood loss and maintain a stable surgical environment. Each medication enhances surgical safety and may shorten procedures by improving visibility and reducing complications.34678
Who Is on the Research Team?
Pushkar Mehra, DMD
Principal Investigator
Oral and Maxillofacial Surgery Department, Boston Medical Center
Are You a Good Fit for This Trial?
This trial is for healthy adults needing jaw surgery at Boston Medical Center, with no home use of beta blockers, calcium channel blockers, or alpha 2 agonists. Participants must not be allergic to the study drugs, should speak English and cannot be pregnant.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-operative
Pre-operative visit to prepare participants for surgery
Surgical Procedure
Participants undergo orthognathic surgery with hypotensive anesthesia using either Dexmedetomidine, Nicardipine, or Labetalol
Post-operative
1-week post-operation visit to assess recovery and collect outcome measures
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Hypotensive Anesthesia
Trial Overview
The trial compares three blood pressure-lowering medications—Dexmedetomidine, Nicardipine, and Labetalol—used during anesthesia in jaw surgery. It's a double-blinded RCT where patients are randomly assigned to one of the three drug groups.
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
Participants randomized into this group will be given Nicardipine to lower their blood pressure during jaw surgery.
Participants randomized into this group will be given Labetalol to lower their blood pressure during jaw surgery.
Participants randomized into this group will be given Dexmedetomidine to lower their blood pressure during jaw surgery.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston Medical Center
Lead Sponsor
Citations
The effect of dexmedetomidine on perioperative events ...
Dexmedetomidine appears to be a safe and effective option for reducing postoperative symptoms such as pain, nausea, vomiting, and cough in orthognathic surgery, ...
Effect of Dexmedetomidine on Blood Loss and Patient ...
Adding-on dexmedetomidine significantly reduced estimated blood loss by over 50% and improves patient outcomes.
Effect of continuous infusion of dexmedetomidine on blood ...
Dexmedetomidine has been used in controlled hypotension and may reduce blood loss in orthognathic surgery. We conducted a retrospective cohort ...
Evaluation of the Advantageous Anesthetic Properties ...
Dexmedetomidine, used as a hypotensive drug, has anesthetic benefits compared with nitroglycerin. Dexmedetomidine decreases the intraoperative fentanyl ...
5.
clinicaltrials.gov
clinicaltrials.gov/study/NCT06093893?term=AREA%5BBasicSearch%5D(AREA%5BBasicSearch%5D(LABETALOL%20HYDROCHLORIDE))&rank=2Hypotensive Anesthesia for Orthognathic Surgery
The outcome measures for the study will be surgical field visibility, estimated blood loss, hemodynamic parameters, operation time, and adverse events. The ...
Effect of Dexmedetomidine on Blood Loss and Patient ...
In conclusion, adding-on dexmedetomidine in orthognathic surgery significantly reduced estimated blood loss by over 50% and improved patient outcomes, ...
Dexmedetomidine infusion on blood loss in orthognathic ...
Our findings demonstrate that dexmedetomidine effectively achieved controlled hypotension during orthognathic surgery, resulting in 217 ml ...
Hypotensive Anesthesia for Orthognathic Surgery
The outcome measures for the study will be surgical field visibility, estimated blood loss, hemodynamic parameters, operation time, and adverse events. The ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.